An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy.
Clicks: 249
ID: 106771
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
69.7
/100
248 views
201 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The therapeutic effect of reactive oxygen species (ROS)-involved cancer therapies is significantly limited by shortage of oxy-substrates, such as hypoxia in photodynamic therapy (PDT) and insufficient hydrogen peroxide (HO) in chemodynamic therapy (CDT). Here, we report a HO/O self-supplying nanoagent, (MSNs@CaO-ICG)@LA, which consists of manganese silicate (MSN)-supported calcium peroxide (CaO) and indocyanine green (ICG) with further surface modification of phase-change material lauric acid (LA). Under laser irradiation, ICG simultaneously generates singlet oxygen and emits heat to melt the LA. The exposed CaO reacts with water to produce O and HO for hypoxia-relieved ICG-mediated PDT and HO-supplying MSN-based CDT, acting as an open source strategy for ROS production. Additionally, the MSNs-induced glutathione depletion protects ROS from scavenging, termed reduce expenditure. This open source and reduce expenditure strategy is effective in inhibiting tumor growth both in vitro and in vivo, and significantly improves ROS generation efficiency from multi-level for ROS-involved cancer therapies.
| Reference Key |
liu2020annature
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Liu, Conghui;Cao, Yu;Cheng, Yaru;Wang, Dongdong;Xu, Tailin;Su, Lei;Zhang, Xueji;Dong, Haifeng; |
| Journal | Nature communications |
| Year | 2020 |
| DOI |
10.1038/s41467-020-15591-4
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.